Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-02

FDA Approved: MOEXIPRIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Moexipril hydrochloride from Teva Pharmaceuticals USA, Inc., updating an existing approval for this ACE inhibito…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moexipril hydrochloride (Moexipril hydrochloride)

Snippet

SUPPL AP for MOEXIPRIL HYDROCHLORIDE (MOEXIPRIL HYDROCHLORIDE)